BioTech Medics, Inc.
BMCS
$0.024
$0.000.00%
| Weiss Ratings | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.19 | |||
| Price History | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 33.33% | |||
| 60-Day Total Return | -8.40% | |||
| 90-Day Total Return | -20.00% | |||
| Year to Date Total Return | -33.15% | |||
| 1-Year Total Return | 370.59% | |||
| 2-Year Total Return | -27.27% | |||
| 3-Year Total Return | -64.18% | |||
| 5-Year Total Return | 1,163.16% | |||
| 52-Week High % Change | -51.02% | |||
| 52-Week Low % Change | 11,900.00% | |||
| Price | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.05 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | May 22, 2023 | |||
| 52-Week High Price (Date) | Nov 17, 2023 | |||
| Valuation | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.93M | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 120.00 | |||
| Price/Book (Q) | 1.40 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 172.36M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 972-274-5533 | |||
| Address | PO Box 93476 Southlake, TX 76092-0114 | |||
| Website | biotecmedics.com | |||
| Country | United States | |||
| Year Founded | 1997 | |||
| Profitability | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -- | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -- | |||
| Balance Sheet | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 15.80K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.95M | |||
| Current Ratio (Q) | 0.007 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 5.07M | |||
| Total Current Liabilities (Q) | 2.12M | |||
| Total Debt (Q) | 28.90K | |||
| Total Liabilities (Q) | 2.12M | |||
| Total Common Equity (Q) | 2.95M | |||
| Cash Flow | BMCS - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
